SANTO

We are glad to welcome you to the section dedicated to SANTO’s export activities! Our company strives to expand its international presence and actively develop partnerships. We are confident that together with you we will be able to achieve significant success and master new horizons.

Denis Fedotov

Export Director of SANTO

Competitive advantages of the work with SANTO

We have a sophisticated and dependable production base. We ensure stringent quality control throughout every phase of production.

SANTO is part of the Polpharma Group – the largest pharmaceutical manufacturer in Central and Eastern Europe.

We are a leader in the Central Asian market with a broad portfolio of quality and certified products.

We are flexible in our approach to each client and respond quickly to requests.

We have a sophisticated and dependable production base. We ensure stringent quality control throughout every phase of production.

SANTO is part of the Polpharma Group – the largest pharmaceutical manufacturer in Central and Eastern Europe.

1 / 4
https://santo.kz/wp-content/uploads/2024/07/advantages_section_image1.png

SANTO is part of the Polpharma Group – the largest pharmaceutical manufacturer in Central and Eastern Europe.

We are a leader in the Central Asian market with a broad portfolio of quality and certified products.

We are flexible in our approach to each client and respond quickly to requests.

https://santo.kz/wp-content/uploads/2024/07/advantages_section_image2.png

We have a sophisticated and dependable production base. We ensure stringent quality control throughout every phase of production.

Export

SANTO, a member of Polpharma Group, is one of the leaders of the pharmaceutical market in Kazakhstan. The company produces more than 240 types of medicine in 12 pharmacological groups.

Of course, the domestic market is a priority for SANTO, but we always look with great interest to new territories. Today we focus on the countries of the Central Asian region and Europe. In the future, we will extend to the Caucasus, MENA and South-East Asia regions.

In 2025, SANTO will become the first pharmaceutical manufacturer in Central Asia to have an EU GMP certificate.We are also actively exploring other markets.

Working with SANTO is a significant expansion of prospects and horizons. If you are not yet our partner, now is the perfect time to join our extensive and successful team.

Working with partners

We follow the course of active development of export destinations. We cooperate with the largest distributors in Mongolia, Turkmenistan and Tajikistan. So, since 2023, we have doubled the volume of sales in Mongolia.

We have reached a long-term agreement with our partners from Turkmenistan.

The first deliveries to Tajikistan were made at the beginning of 2024. We already have excellent indicators, but we continue to work on improving them on a daily basis.

According to IQVIA, SANTO is a leader with a steady increase in market share in Kyrgyzstan. We provide strong sales growth in the Uzbekistan market, where we are included in the list of leading companies.

Our strong side is taking into account the needs of local markets, which requires constant work on expanding the drug portfolio and registering new medicine. We clearly understand the demand for medicines of various nosologies, medicinal forms and dosage forms. We make every effort to meet the demand of the healthcare system in various countries.

SANTO is open to offers from potential and reliable partners from all over the world. We are proud of our products and services and value every new collaboration that promotes mutual growth and development.

If you are interested in working with us, please send your commercial offers to the following email address:

santo.export@santo.kz

We are looking forward to your suggestions and are ready to discuss the possibilities of our future together.

Collaboration models

We are grateful for the flexibility in logistics organization and offer the following options: delivery by a partner (EXW) or delivery by SANTO (CIP, CIF, CFR, FOB).

We are based on the distribution model. You buy products and sell them in your own markets with flexible pricing and marketing support. We offer a certain level of discounts, which we can consider in an individual format.

Another format of cooperation is license. It assumes that partners can produce and sell our products under the SANTO brand in their respective markets. This is an opportunity to use our best practices and experience to achieve success.

Promising geographical destinations

As of the first quarter of 2024, SANTO is negotiating with 10 countries from the Caucasus, MENA and Southeast Asia. We are open to expanding our collaboration in other regions as well.

On a regular basis, we conduct research, evaluate the possibility of entering new markets and increasing the share of sales in our branches.

When entering new markets, SANTO relies on a rich experience in the Central Asian and other regions.

The company’s remarkable success even in markets that are “closed” from the point of view of market research confirms that the strategy is working.